Table 3.
Baseline characteristics of patients with low- and high-density stromal PMNs.
| Low density (n = 90) | High density (n = 36) | P | |||
|---|---|---|---|---|---|
| No. | % | No. | % | ||
| Median age (range) | 48 (29-70) | 47 (30-68) | 0.741 | ||
| Clinical stage | 0.007 | ||||
| I/II | 74 | 82.2 | 25 | 69.4 | |
| III/IV | 16 | 17.8 | 11 | 30.6 | |
| Histology | 0.447 | ||||
| SCC | 84 | 93.4 | 32 | 88.9 | |
| No SCC | 6 | 6.6 | 4 | 11.1 | |
| Grade | 0.238 | ||||
| 1-2 | 10 | 11.1 | 4 | 11.1 | |
| 3 | 60 | 66.7 | 31 | 86.1 | |
| Unknown | 20 | 22.2 | 1 | 2.8 | |
| Lymph node | 0.056 | ||||
| Negative | 76 | 84.4 | 25 | 69.4 | |
| Positive | 14 | 15.6 | 11 | 30.6 | |
PMN, polymorphonuclear neutrophil; SCC, squamous cell carcinoma.